313 related articles for article (PubMed ID: 31828868)
21. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.
Wang W; Corrigan-Cummins M; Barber EA; Saleh LM; Zingone A; Ghafoor A; Costello R; Zhang Y; Kurlander RJ; Korde N; Roccaro AM; Ghobrial IM; Landgren O; Calvo KR
J Mol Diagn; 2015 Nov; 17(6):669-78. PubMed ID: 26433312
[TBL] [Abstract][Full Text] [Related]
22. Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma.
Zhang ZY; Li YC; Geng CY; Wang HJ; Chen WM
Biomed Res Int; 2019; 2019():1575468. PubMed ID: 31915680
[TBL] [Abstract][Full Text] [Related]
23. Exosomal microRNA: a novel biomarker for breast cancer.
He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
[TBL] [Abstract][Full Text] [Related]
24. Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: Opportunities and challenges.
Ramezani A; Tafazoli A; Salimi F; Ghavami M; Arjmandi H; Khalesi B; Hashemi ZS; Khalili S
Arch Biochem Biophys; 2024 Jun; 756():109994. PubMed ID: 38626818
[TBL] [Abstract][Full Text] [Related]
25. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
Gupta N; Kumar R; Seth T; Garg B; Sharma A
RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
[TBL] [Abstract][Full Text] [Related]
26. The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer.
Liu Q; Peng F; Chen J
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395836
[TBL] [Abstract][Full Text] [Related]
27. Exosomes in cancer: Small transporters with big functions.
Li X; Wang Y; Wang Q; Liu Y; Bao W; Wu S
Cancer Lett; 2018 Oct; 435():55-65. PubMed ID: 30071288
[TBL] [Abstract][Full Text] [Related]
28. The role of exosomes and miRNAs in drug-resistance of cancer cells.
Bach DH; Hong JY; Park HJ; Lee SK
Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776
[TBL] [Abstract][Full Text] [Related]
29. Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling.
Ho M; Chen T; Liu J; Dowling P; Hideshima T; Zhang L; Morelli E; Camci-Unal G; Wu X; Tai YT; Wen K; Samur M; Schlossman RL; Mazitschek R; Kavanagh EL; Lindsay S; Harada T; McCann A; Anderson KC; O'Gorman P; Bianchi G
Leukemia; 2020 Jan; 34(1):196-209. PubMed ID: 31142847
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs in the pathobiology of multiple myeloma.
Lionetti M; Agnelli L; Lombardi L; Tassone P; Neri A
Curr Cancer Drug Targets; 2012 Sep; 12(7):823-37. PubMed ID: 22671930
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
[TBL] [Abstract][Full Text] [Related]
32. Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance.
Manni S; Carrino M; Semenzato G; Piazza F
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783691
[TBL] [Abstract][Full Text] [Related]
33. Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.
Mao L; Li J; Chen WX; Cai YQ; Yu DD; Zhong SL; Zhao JH; Zhou JW; Tang JH
Tumour Biol; 2016 Apr; 37(4):5247-56. PubMed ID: 26555545
[TBL] [Abstract][Full Text] [Related]
34. Altered Expression of MicroRNAs in the Bone Marrow of Multiple Myeloma Patients and their Relationship to Cytogenetic Aberrations.
Attia HRM; Abdelrahman AH; Ibrahim MH; Eid MM; Eid OM; Sallam MT; El Gammal MM; Kamel MM
Curr Pharm Biotechnol; 2020; 21(13):1394-1401. PubMed ID: 32196445
[TBL] [Abstract][Full Text] [Related]
35. Aberrant microRNA expression in multiple myeloma.
Dimopoulos K; Gimsing P; Grønbæk K
Eur J Haematol; 2013 Aug; 91(2):95-105. PubMed ID: 23586898
[TBL] [Abstract][Full Text] [Related]
36. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
[TBL] [Abstract][Full Text] [Related]
37. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.
Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357
[TBL] [Abstract][Full Text] [Related]
38. RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer.
Cheng WC; Liao TT; Lin CC; Yuan LE; Lan HY; Lin HH; Teng HW; Chang HC; Lin CH; Yang CY; Huang SC; Jiang JK; Yang SH; Yang MH; Hwang WL
Int J Cancer; 2019 Oct; 145(8):2209-2224. PubMed ID: 30980673
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells.
Anfossi S; Fu X; Nagvekar R; Calin GA
Adv Exp Med Biol; 2018; 1056():87-108. PubMed ID: 29754176
[TBL] [Abstract][Full Text] [Related]
40. miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.
Tavakoli Pirzaman A; Ebrahimi P; Hasanpour AH; Shakeri M; Babajani B; Pourali Ganji Z; Babaei H; Rahmati A; Hosseinzadeh R; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231202391. PubMed ID: 37728167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
